Towards Healthcare
Oncology Drugs Market to Lead USD 360.79 Bn by 2034

Oncology Drugs Market Driven by Targeted Therapies

According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, as poor lifestyle, longer working period, progressively stressful lives, alcohol consumption, smoking, increasing use of contraception, nulliparity, and reduced breastfeeding are all contributing to increasing cancer cases. North America is dominant in the market due to increasing R&D investment and a strong regulatory environment.

Content

  • Insight Code: 6206
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The oncology drugs market stands at USD 217.18 billion in 2025 and is expected to reach USD 360.79 billion by 2034, growing at a CAGR of 6.29% from 2024 to 2034.

North America is currently leading the oncology drugs market share by 40% due to advanced healthcare infrastructure and the presence of major healthcare players.

The oncology drugs market includes five segments: by drug class, by indication, by therapy type, by distribution channel, and by region.

Oncology drugs are medications used to diagnose, treat, and manage cancer by targeting and controlling the growth and spread of abnormal cells.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions